Sorensen Mel
Insider CIK 1444783 · GRTX President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GRTX Galera Therapeutics, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-05 | 30,000 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | D To issuer | 2026-08-03 | 2026-08-05 | 975 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-05 | 30,000 | — | — | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | D To issuer | 2026-08-03 | 2026-08-05 | 975 | — | — | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 70,000 | $0.02 | $1.4K | 195,029 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2025-05-01 | 2025-05-05 | 6,000,000 | — | $0 | 6,000,000 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | S Sale | 2024-08-16 | 2024-08-20 | 67,015 | $0.07 | $4.7K | 265,029 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | P Buy | 2023-03-10 | 2023-03-14 | 100,000 | $1.68 | $168.0K | 332,044 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2023-02-25 | 2023-02-28 | 440,000 | — | $0 | 440,000 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2022-02-28 | 2022-03-02 | 264,400 | — | $0 | 264,400 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | M Exercise deriv | 2021-03-26 | 2021-03-30 | 46,940 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | M Exercise deriv | 2021-03-26 | 2021-03-30 | 170,075 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | M Exercise | 2021-03-26 | 2021-03-30 | 46,940 | $1.14 | $53.5K | 232,044 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | M Exercise | 2021-03-26 | 2021-03-30 | 170,075 | $1.07 | $182.0K | 185,104 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2021-01-26 | 2021-01-28 | 190,000 | — | $0 | 190,000 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2020-01-31 | 2020-02-04 | 186,087 | — | $0 | 186,087 | SEC↗ |